Vandetanib and Lenvatinib for the Treatment of Thyroid Cancers
Hye-Hyun Kim & Sun-Young Han · Journal of Advances in Medicine and Medical Research · 2019
Several drugs with Rearranged during Transfection (RET) kinase-inhibitory activity were recently introduced for thyroid cancer patients. RET gene aberrations were found in differentiated thyroid cancers and medullary thyroid cancers, subsets of thyroid cancers. Rearrangement of R...
Open access
Research Article
10.9734/JAMMR/2018/46474